Clinical use of immune serum globulin as replacement therapy in patients with primary immunodeficiency syndromes Stanley A. Schwartz OriginalPaper Pages: 1 - 12
Current status of intravenous immunoglobuiin in preventing or treating neonatal bacterial infections Leonard E. WeismanDavid F. CruessGerald W. Fischer OriginalPaper Pages: 13 - 28
The potential use of monoclonal antibodies as therapeutic modalities in neonatal infection Harry R. HillLuis Antonio GonzalesHoward V. Raff OriginalPaper Pages: 29 - 38
Immune deficiencies in chronic lymphocytic leukemia and multiple myeloma Alan WinkelsteinP. Susan Jordan OriginalPaper Pages: 39 - 58
IVIG in the treatment of children with acute and chronic ldiopathic thrombocytopenic purpura and the autoimmune cytopenias Diane J. Nugent OriginalPaper Pages: 59 - 71
IVIG therapy in neonatal isoimmune thrombocytopenic purpura and alloimmunization thrombocytopenia Joanne KurtzhergKimberly P. Dunsmore OriginalPaper Pages: 73 - 80
The clinical efficacy of IVGG in Kawasaki disease Anne H. RowleyStanford T. Shuiman OriginalPaper Pages: 81 - 91
The immunoregulatory effects of IVIG in Kawasaki disease and other autoimmune diseases Donald Y. M. Leung OriginalPaper Pages: 93 - 104
The role of IVIG in the management of patients with antiphospholipid antibodies and recurrent pregnancy losses Ann Parke OriginalPaper Pages: 105 - 118